In patients with early Parkinson's disease, levels of urate in both serum and cerebrospinal fluid show a robust inverse correlation with clinical progression, according to a new analysis of data from the multicenter Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study.
PREVIEW